2021
Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)
Anders H, Rovin B, Zhao M, Malvar A, Hiromura K, Jones-Leone A, González-Rivera T, Gilbride J, Madan A, Green Y, Roth D. Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN). Journal Of The American Society Of Nephrology 2021, 32: 48-49. DOI: 10.1681/asn.20213210s148c.Peer-Reviewed Original Research
2020
Belimumab (BEL) Improves Renal Outcomes in Active Lupus Nephritis (LN): A Phase 3 Randomized, Placebo (PBO)-Controlled Trial
Rovin B, Houssiau F, Furie R, Malvar A, Teng Y, Mok C, Contreras G, Yu X, Dolff S, Ji B, Roth D, Kleoudis C, Makowiak S, Madan A, Gilbride J, Green Y. Belimumab (BEL) Improves Renal Outcomes in Active Lupus Nephritis (LN): A Phase 3 Randomized, Placebo (PBO)-Controlled Trial. Journal Of The American Society Of Nephrology 2020, 31: 54-54. DOI: 10.1681/asn.20203110s154a.Peer-Reviewed Original Research